|
GB0000564D0
(en)
*
|
2000-01-11 |
2000-03-01 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US6958334B2
(en)
|
2001-04-10 |
2005-10-25 |
Merck & Co., Inc. |
Inhibitors of Akt activity
|
|
WO2002083139A1
(en)
|
2001-04-10 |
2002-10-24 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
|
US6960584B2
(en)
|
2001-04-10 |
2005-11-01 |
Merck & Co., Inc. |
Inhibitors of Akt activity
|
|
WO2004048980A1
(en)
*
|
2002-11-28 |
2004-06-10 |
Neurosearch A/S |
Method for screening for compounds as potential sedatives or anxiolytics
|
|
WO2006061428A2
(en)
*
|
2004-12-10 |
2006-06-15 |
Universität Zürich |
Gaba-a alpha 2 and alpha 3 receptor agonists for treating neuropathic, inflammatory and migraine associated pain
|
|
EP2275095A3
(en)
|
2005-08-26 |
2011-08-17 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation
|
|
EP2258358A3
(en)
|
2005-08-26 |
2011-09-07 |
Braincells, Inc. |
Neurogenesis with acetylcholinesterase inhibitor
|
|
EP1940389A2
(en)
|
2005-10-21 |
2008-07-09 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
|
AU2006308889A1
(en)
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
GABA receptor mediated modulation of neurogenesis
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
JP2009536667A
(ja)
|
2006-05-09 |
2009-10-15 |
ブレインセルス，インコーポレイティド |
５ｈｔ受容体介在性の神経新生
|
|
EP2382975A3
(en)
|
2006-05-09 |
2012-02-29 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
AU2007292848A1
(en)
|
2006-09-08 |
2008-03-13 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
|
CN104098578A
(zh)
*
|
2008-08-29 |
2014-10-15 |
康瑟特制药公司 |
取代的三唑并哒嗪衍生物
|
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
JP2012531419A
(ja)
|
2009-06-23 |
2012-12-10 |
コンサート ファーマシューティカルズ インコーポレイテッド |
Ｇａｂａ−ａ受容体修飾物質としての重水素修飾されたトリアゾロピリダジン誘導体
|
|
WO2011047315A1
(en)
|
2009-10-15 |
2011-04-21 |
Concert Pharmaceuticals, Inc. |
Subsitituted benzimidazoles
|
|
US20150158870A1
(en)
*
|
2012-05-11 |
2015-06-11 |
Concert Pharmaceuticals Inc. |
Polymorphs of 7-(tert-butyl-d9)-3-(2,5-difluorophenyl)-6-((1-methyl-1h-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolo[4,3-b]pyridazine
|
|
US20150099753A1
(en)
*
|
2012-05-11 |
2015-04-09 |
Concert Pharmaceuticals Inc. |
Form 5 polymorph of 7-(tert-butyl-d9)-3-(2,5-difluorophenyl)-6-((1-methyl-1h-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolo[4,3-b]pyridazine
|
|
WO2013170242A1
(en)
*
|
2012-05-11 |
2013-11-14 |
Concert Pharmaceuticals, Inc. |
Form 2 polymorph of 7-(tert-butyl-d9)-3-(2,5-difluorophenyl)-6-((1-methyl-1h-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolo[4,3-b]pyridazine
|
|
WO2015095549A1
(en)
*
|
2013-12-18 |
2015-06-25 |
Concert Pharmaceuticals, Inc. |
Dosage regimen for gabaa receptor subtype selective drug
|
|
BR112021004661A2
(pt)
*
|
2018-09-13 |
2021-06-01 |
Saniona A/S |
composto, composição farmacêutica, método para tratamento de dor neuropática e/ou prurido, e, uso do composto
|
|
EP4511025A4
(en)
*
|
2022-04-20 |
2026-04-15 |
Engrail Therapeutics Inc |
GABAa receptor modulator salts, particles, and their uses
|
|
CN115837022B
(zh)
*
|
2023-02-20 |
2023-04-25 |
中山大学附属第八医院（深圳福田） |
1,2,4三唑并4,3-b哒嗪衍生物在制备抗衰老药物中的应用
|
|
WO2025141131A1
(en)
|
2023-12-27 |
2025-07-03 |
Saniona A/S |
A gabaa receptor ligand and the use thereof in medicine, in particular in the treatment of epilepsy
|